Pneumonia investment doesn't match mortality burden
Of all infectious disease research investment between 2011-2013 (£917 million), £28.8 million (3.1 per cent) went to pneumonia. Translational research, which applies findings to a health care setting, accounted for 33.3 per cent of this spend, compared with 1997-2010 when funding was almost entirely preclinical. High-burden areas such as paediatrics, elderly care and antimicrobial resistance received little investment.
"Antimicrobial resistance is an under-resourced area across all investments for infectious disease research, and pneumonia is no exception," says lead author Michael Head of UCL and Southampton. "Globally, resistance to some strains of pneumonia is increasing, so it is imperative to increase development in the R&D pipeline of new antibacterial therapies, especially infections that are acquired in-hospitals, where the pathogens are highly resistant."
The European Commission provided the largest proportion of pneumonia research investments between 2011 and 2013 (31.2 per cent) through six large awards, amounting to £9.2 million. The second largest contribution was from the Bill & Melinda Gates Foundation, which provided £7·4 million (26.6 per cent) of investment across five awards.
Between 1997 and 2010, the Wellcome Trust was the leading funder of UK-awarded pneumonia research (then 44.8 per cent of the total, now 15.9 per cent).
Professor Marie-Louise Newell, Head of the Global Health Research Institute at Southampton, says: "The study highlights the demand for a comprehensive overview of where infectious disease research spending is being made on global level to ensure that resources are allocated wisely and funding gaps are avoided."
INFORMATION:
Notes for editors
1. For a full copy of the paper Mapping pneumonia research: a systematic analysis of UK investments and published outputs 1997-2013 please contact Steven Williams, Media Relations, University of Southampton, Tel: 023 8059 2128, email: S.Williams@soton.ac.uk
2. For interview opportunities with the academics, please contact media relations.
3. Through world-leading research and enterprise activities, the University of Southampton connects with businesses to create real-world solutions to global issues. Through its educational offering, it works with partners around the world to offer relevant, flexible education, which trains students for jobs not even thought of. This connectivity is what sets Southampton apart from the rest; we make connections and change the world. http://www.southampton.ac.uk/
http://www.southampton.ac.uk/weareconnected
For further information contact:
Steven Williams, Media Relations, University of Southampton, Tel: 023 8059 2128, email: S.Williams@soton.ac.uk
http://www.soton.ac.uk/mediacentre/
Follow us on twitter: http://twitter.com/unisouthampton
Like us on Facebook: http://www.facebook.com/unisouthampton